Skip to main content

Assembly Biosciences, Inc.

ASMB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001426800

No open-market purchases or sales by Assembly Biosciences, Inc. insiders were filed in the last 90 days; 92 institutions reported holding it in 13F filings for Q2 2026, worth $514.8M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Assembly Biosciences, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of ASMB: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders5450−4
Shares17.2M16.6M−594.2K (−3.5%)
Value$36.1M$27.2M−$8.88M (−24.6%)

New holders (4)

Institutions that held Assembly Biosciences, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to ASMB in Q3 2022
InstitutionSharesValue% of portfolio
Healthcare of Ontario Pension Plan Trust Fund570,300$935.0K0.00%
Virtu Financial LLC30,046$49.0K0.00%
Occudo Quantitative Strategies LP12,440$20.0K0.00%
Royal Bank of Canada187$00.00%

Sold out (8)

Institutions that held Assembly Biosciences, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of ASMB in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Crestline Management, LP42,513$89.0K
GAM Holding AG24,100$51.0K
HRT Financial LP21,030$44.0K
Engineers Gate Manager LP19,134$40.0K
XTX Topco Ltd13,207$28.0K
Ameriprise Financial Inc10,145$21.0K
Krensavage Asset Management, LLC9,985$21.0K
Cutler Group LP200$0